Success stories

  • Data analysis as an instrument for improvement in hospital management and research

    The innovation unit of the Hospital Clínico San Carlos analyzes thousands of data generated by hospital activity in order to improve management and research in health.

  • The intelligent system to avoid errors in pharmacotherapy born in HGUGM is implemented in Murcia

    The Hospital Pharmacy Research and Innovation Group of the Hospital General Universitario Gregorio Marañón (#HGUGM), in collaboration with the Hospital Information Systems Department and with the participation of doctors from different Services, has developed a #IntelligentSystem that helps to cross in real time the clinical data of the patient and generates alerts about the convenience of the scheduled #treatments. The new system guarantees an effective, safe and efficient #pharmacotherapy; a rational and safe use of medicines; promotes health strategies based on data analysis and contains #health spending (with an estimated #saving of more than one million euros per year). It has already been implemented in the HGUGM, and also in other hospitals of the National Health System such as the Virgen de la Arrixaca University Clinical Hospital (Murcia).

  • Tests that allow diagnosing and treating pathologies in which the body inflames the brain itself

    The Clinical and Experimental Neuroimmunology team at the Institut d'investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Hospital Clínic, led by Dr. Josep Dalmau, has developed several technologies that make it possible to diagnose, predict and treat patients suffering from autoimmune neurological diseases ( the body itself attacks and inflames the brain). These pathologies manifest with memory deficits, behavioral disturbances, epileptic seizures, movement disturbances, psychosis, and sleep disturbances. These new diagnostic tests have been licensed with the support of the IDIBAPS Knowledge and Technology Transfer Office and the ITEMAS Medical and Health Technologies Platform.

  • Aptamers against MNK1 for the treatment of breast cancer

    Researchers at the Instituto Ramón y Cajal de Investigación Sanitaria have demonstrated the efficacy of laboratory-made DNA / RNA molecules, aptamers, against breast cancer in animals and cell lines.